» Articles » PMID: 36163029

Circulating Serum Metabolites As Predictors of Dementia: a Machine Learning Approach in a 21-year Follow-up of the Whitehall II Cohort Study

Overview
Journal BMC Med
Publisher Biomed Central
Specialty General Medicine
Date 2022 Sep 26
PMID 36163029
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Age is the strongest risk factor for dementia and there is considerable interest in identifying scalable, blood-based biomarkers in predicting dementia. We examined the role of midlife serum metabolites using a machine learning approach and determined whether the selected metabolites improved prediction accuracy beyond the effect of age.

Methods: Five thousand three hundred seventy-four participants from the Whitehall II study, mean age 55.8 (standard deviation (SD) 6.0) years in 1997-1999 when 233 metabolites were quantified using nuclear magnetic resonance metabolomics. Participants were followed for a median 21.0 (IQR 20.4, 21.7) years for clinically-diagnosed dementia (N=329). Elastic net penalized Cox regression with 100 repetitions of nested cross-validation was used to select models that improved prediction accuracy for incident dementia compared to an age-only model. Risk scores reflecting the frequency with which predictors appeared in the selected models were constructed, and their predictive accuracy was examined using Royston's R, Akaike's information criterion, sensitivity, specificity, C-statistic and calibration.

Results: Sixteen of the 100 models had a better c-statistic compared to an age-only model and 15 metabolites were selected at least once in all 16 models with glucose present in all models. Five risk scores, reflecting the frequency of selection of metabolites, and a 1-SD increment in all five risk scores was associated with higher dementia risk (HR between 3.13 and 3.26). Three of these, constituted of 4, 5 and 15 metabolites, had better prediction accuracy (c-statistic from 0.788 to 0.796) compared to an age-only model (c-statistic 0.780), all p<0.05.

Conclusions: Although there was robust evidence for the role of glucose in dementia, metabolites measured in midlife made only a modest contribution to dementia prediction once age was taken into account.

Citing Articles

Circulating metabolome in relation to cognitive impairment: a community-based cohort of older adults.

Huang Y, Sun X, Huang Q, Huang Q, Chen X, Zhou X Transl Psychiatry. 2024; 14(1):469.

PMID: 39528482 PMC: 11554788. DOI: 10.1038/s41398-024-03147-9.


Blood protein assessment of leading incident diseases and mortality in the UK Biobank.

Gadd D, Hillary R, Kuncheva Z, Mangelis T, Cheng Y, Dissanayake M Nat Aging. 2024; 4(7):939-948.

PMID: 38987645 PMC: 11257969. DOI: 10.1038/s43587-024-00655-7.


Circulating Metabolite Profiles and Risk of Coronary Heart Disease Among Racially and Geographically Diverse Populations.

Deng K, Gupta D, Shu X, Lipworth L, Zheng W, Cai H Circ Genom Precis Med. 2024; 17(4):e004437.

PMID: 38950084 PMC: 11335450. DOI: 10.1161/CIRCGEN.123.004437.


Multi-Omic Blood Biomarkers as Dynamic Risk Predictors in Late-Onset Alzheimer's Disease.

Bhalala O, Watson R, Yassi N Int J Mol Sci. 2024; 25(2).

PMID: 38279230 PMC: 10816901. DOI: 10.3390/ijms25021231.


Plasma metabolic profiles predict future dementia and dementia subtypes: a prospective analysis of 274,160 participants.

Qiang Y, You J, He X, Guo Y, Deng Y, Gao P Alzheimers Res Ther. 2024; 16(1):16.

PMID: 38254212 PMC: 10802055. DOI: 10.1186/s13195-023-01379-3.


References
1.
Silverberg N, Elliott C, Ryan L, Masliah E, Hodes R . NIA commentary on the NIA-AA Research Framework: Towards a biological definition of Alzheimer's disease. Alzheimers Dement. 2018; 14(4):576-578. DOI: 10.1016/j.jalz.2018.03.004. View

2.
Soininen P, Kangas A, Wurtz P, Suna T, Ala-Korpela M . Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics. Circ Cardiovasc Genet. 2015; 8(1):192-206. DOI: 10.1161/CIRCGENETICS.114.000216. View

3.
Kellar D, Craft S . Brain insulin resistance in Alzheimer's disease and related disorders: mechanisms and therapeutic approaches. Lancet Neurol. 2020; 19(9):758-766. PMC: 9661919. DOI: 10.1016/S1474-4422(20)30231-3. View

4.
Tynkkynen J, Chouraki V, van der Lee S, Hernesniemi J, Yang Q, Li S . Association of branched-chain amino acids and other circulating metabolites with risk of incident dementia and Alzheimer's disease: A prospective study in eight cohorts. Alzheimers Dement. 2018; 14(6):723-733. PMC: 6082422. DOI: 10.1016/j.jalz.2018.01.003. View

5.
Crane P, Walker R, Hubbard R, Li G, Nathan D, Zheng H . Glucose levels and risk of dementia. N Engl J Med. 2013; 369(6):540-8. PMC: 3955123. DOI: 10.1056/NEJMoa1215740. View